Getting older is inevitable, but aging may be optional, or at least a treatable condition. Increasingly, researchers are parsing the particulars of aging, the ways in which the human body becomes less healthy over time.
Aging research is always timely, and here’s a date: On March 6, the San Diego Nathan Shock Center, a consortium of Sanford Burnham Prebys, Salk and UC San Diego, will hold its second annual Symposium on the Heterogeneity of Aging at the Salk Institute.
Designated by the United Nations, the 9th International Day of Women and Girls in Science is Sunday, February 11, preceded by two days of meetings, presentations and outreach among global leaders, with a focus on women scientific leadership in sustainable development.
Rare diseases are conditions that afflict less than 200,000 people in the United States, but they are far less rare in the aggregate, afflicting millions—and in their disparate types: There are more than 10,000 known rare diseases. In his latest essay in the UT, David Brenner discusses the particular challenges of identifying and developing treatments for rare diseases, and the work being done at the Sanford Children’s Health Research Center.
Carbapenems are a class of highly effective antibiotics that are often used to treat severe bacterial infections. They are usually reserved for known or suspected bacterial infections resistant to other drugs.
In David Brenner’s latest essay in the San Diego Union-Tribune, he describes how technological advances, from complex cell cultures and organoids to computational models driven by artificial intelligence are increasingly lessening the need to rely upon problematic animal testing for new drugs and therapies – and why they are more likely to directly and effectively inform research and future success.
A valuable career and professional development opportunity, this event showcases the biomedical research of exceptional scientists nearing the completion of their doctoral degree or in all stages of postdoctoral training.
This one day event will showcase expert scientists who are making impactful contributions to the field of pancreatic cancer research, including tumorigenesis, tumor progression, and the discovery of novel therapeutic paradigms, such as immunomodulation and metabolic targeting